MedPage Today -- CAPE TOWN, July 22 -- Doctors should consider dropping non-active drugs from the revised regimens of HIV patients who are experiencing treatment failure, researchers suggested here. Typically these inactive components are nucleoside reverse transcriptase inhibitors, according to Benoit Trottier, MD, research medical director at Clinique Medicale l’Actuel in Montreal.
